In vivo imaging of synaptic density in virally suppressed HIV-1 infection using 11CUCB-J PET

使用 11CUCB-J PET 对病毒抑制的 HIV-1 感染中的突触密度进行体内成像

基本信息

  • 批准号:
    9622028
  • 负责人:
  • 金额:
    $ 25.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-06-15 至 2020-04-30
  • 项目状态:
    已结题

项目摘要

The most pressing neurologic priorities relevant to the 37 million people living with HIV (PLWH) worldwide are to identify causes of central nervous system (CNS) dysfunction during virally suppressive combination antiretroviral therapy (cART) and interventions to correct them. Gaps in our understanding of the biological basis of HIV associated neurocognitive disorder (HAND) during cART impede progress in ameliorating neurocognitive impairment in long-term surviving PLWH. More than 20 years ago, reduced synaptic density was recognized as the primary pathology in autopsy specimens from HIV infected donors with mild forms of cognitive impairment at the time of death. Reduction in density of synaptophysin-immunoreactive terminals was identified in early stage impairment, in the absence of classical findings of HIV encephalitis. These compelling findings set the groundwork for subsequent important preclinical in vitro and animal studies revealing further understanding of reduced synaptic density in HIV, including regional vulnerability, contributory mechanisms, and potential interventions. However, confirmation of these findings and further investigation has not been possible to date in living, virologically suppressed humans due to lack of access to brain tissue samples. Additionally, unlike frank neuronal loss, synaptodendritic injury may be reversible. Thus, the ability to detect decreases in synaptic density in living humans and to identify potential mechanisms that correlate to its presence would guide therapeutic approaches and provide a critical biomarker for monitoring effects of novel therapeutics to reduce brain dysfunction in HIV. This application capitalizes on recent unprecedented expansion of imaging technologies to apply the understanding gained by pre-clinical studies to investigation of synaptic density in living humans. We have recently developed a novel radiotracer, 11C—UCB—J, for imaging synaptic density in the human brain using positron- emission tomography (PET). In the proposed research studies, we will apply this breakthrough methodology to explore whether observations of decreased synaptic density in postmortem human samples and animal models will be found living PLWH with suppressed HIV replication. Further exploratory studies will investigate associations between synaptic density and laboratory and clinical measures implicated by preclinical studies, including levels of systemic and CNS immune activation and history of opioid use. Our pilot study validating this modality as a means to detect aberrant synaptic density in cART-treated HIV will have a major impact, setting the stage for future studies of the relationship of synaptic density to clinical outcomes of HAND, and providing a therapeutic target and a biomarker for treatment studies aimed to improve HIV-related injury in the CNS.
与全世界3700万艾滋病毒感染者(PLWH)相关的最紧迫的神经学优先事项是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SERENA S SPUDICH其他文献

SERENA S SPUDICH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SERENA S SPUDICH', 18)}}的其他基金

PET IMAGING OF SYNAPTIC DENSITY COMBINED WITH NEUROIMMUNOLOGIC MEASURES TO REVEAL MECHANISMS OF HIV NEUROPATHOGENESIS DURING ART
突触密度 PET 成像结合神经免疫学措施揭示艺术期间 HIV 神经发病机制
  • 批准号:
    10263367
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
PET IMAGING OF SYNAPTIC DENSITY COMBINED WITH NEUROIMMUNOLOGIC MEASURES TO REVEAL MECHANISMS OF HIV NEUROPATHOGENESIS DURING ART
突触密度 PET 成像结合神经免疫学措施揭示艺术期间 HIV 神经发病机制
  • 批准号:
    10686890
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)
耶鲁临床中心:耶鲁改善神经治疗的调查(INFINITY)
  • 批准号:
    10447762
  • 财政年份:
    2018
  • 资助金额:
    $ 25.13万
  • 项目类别:
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)
耶鲁临床中心:耶鲁改善神经治疗的调查(INFINITY)
  • 批准号:
    9981450
  • 财政年份:
    2018
  • 资助金额:
    $ 25.13万
  • 项目类别:
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)
耶鲁临床中心:耶鲁改善神经治疗的调查(INFINITY)
  • 批准号:
    10198051
  • 财政年份:
    2018
  • 资助金额:
    $ 25.13万
  • 项目类别:
Critical Role of Cytotoxic T Cells in HIV Neuropathogenesis
细胞毒性 T 细胞在 HIV 神经发病机制中的关键作用
  • 批准号:
    9341385
  • 财政年份:
    2016
  • 资助金额:
    $ 25.13万
  • 项目类别:
Long-Term CNS Consequences of Treatment During Acute Infection
急性感染期间治疗的长期中枢神经系统后果
  • 批准号:
    8307295
  • 财政年份:
    2011
  • 资助金额:
    $ 25.13万
  • 项目类别:
Long-Term CNS Consequences of Treatment During Acute Infection
急性感染期间治疗的长期中枢神经系统后果
  • 批准号:
    8663961
  • 财政年份:
    2011
  • 资助金额:
    $ 25.13万
  • 项目类别:
Long-Term CNS Consequences of Treatment During Acute Infection
急性感染期间治疗的长期中枢神经系统后果
  • 批准号:
    8472533
  • 财政年份:
    2011
  • 资助金额:
    $ 25.13万
  • 项目类别:
Long-Term CNS Consequences of Treatment During Acute Infection
急性感染期间治疗的长期中枢神经系统后果
  • 批准号:
    8499495
  • 财政年份:
    2011
  • 资助金额:
    $ 25.13万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 25.13万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 25.13万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 25.13万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 25.13万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 25.13万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 25.13万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 25.13万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 25.13万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 25.13万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 25.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了